nach oben

Erschienen in:

30.03.2021 | Review

Adverse Events and Complications with Intragastric Balloons: a Narrative Review (with Video)

Erschienen in: Obesity Surgery | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Intragastric balloon (IGB) is a minimally invasive and reversible therapy for weight loss with a good efficacy and safety profile. Introduced in the 1980s, IGBs have significantly evolved in the last couple of decades. They mechanically act by decreasing the volume of the stomach and its reservoir capacity, delaying gastric emptying, and increasing satiety leading to a subsequent weight loss. Despite the low rates of complications and mortality associated with IGBs, adverse events and complications still occur and can range from mild to fatal. This review aims to provide an update on the current scientific evidence in regard to complications and adverse effects of the use of the IGB and its treatment. This is the first comprehensive narrative review in the literature dedicated to this subject.

Graphical abstract

Nur mit Berechtigung zugänglich

Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the council of the obesity society. Obesity. 2008. p. 1161–77.

Espinet-Coll E, Nebreda-Durán J, Gómez-Valero JA, Muñoz-Navas M, Pujol-Gebelli J, Vila-Lolo C, et al. Current endoscopic techniques in the treatment of obesity. Rev. Esp. Enfermedades Dig. 2012. p. 72–87.

Kumar N, Sullivan S, Thompson CC. The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy. Diabetes, Metab Syndr Obes Targets Ther. 2017;10:311–6.CrossRef

de Moura EGH, Ribeiro IB, Frazão MSV, et al. EUS-guided intragastric injection of botulinum toxin A in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg. 2019;29:32–9. https://doi.org/10.1007/s11695-018-3470-y

Gyring Nieben O, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;319:198–9.CrossRef

Moura D, Oliveira J, De Moura EGH, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis [Internet]. 2016;12:420–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26968503CrossRef

Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30:2743–53. https://doi.org/10.1007/s11695-020-04558-5

ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc [Internet]. 2015;82:425–38.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26232362CrossRef

Lopez-Nava G, Jaruvongvanich V, Storm AC, et al. Personalization of endoscopic bariatric and metabolic therapies based on physiology: a prospective feasibility study with a single fluid-filled intragastric balloon. Obes Surg [Internet]. 2020;30:3347–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32285333CrossRef

10.

Patel NJ, Gómez V, Steidley DE, et al. Successful use of intragastric balloon therapy as a bridge to heart transplantation. Obes Surg [Internet]. 2020;30:3610–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32279183CrossRef

11.

Saber AA, Shoar S, Almadani MW, et al. Efficacy of first-time intragastric balloon in weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Surg [Internet]. 2017;27:277–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27465936CrossRef

12.

Neto MG, Silva LB, Grecco E, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis [Internet]. 2018;14:151–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29108896CrossRef

13.

Hay D, Ryan G, Somasundaram M, et al. Laparoscopic management of a migrated intragastric balloon causing mechanical small bowel obstruction: a case report and review of the literature. Ann R Coll Surg Engl [Internet]. 2019;101:e172–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31672034CrossRef

14.

Caruso R, Vicente E, Quijano Y, et al. A combined laparoscopic and endoscopic approach for an early gastric perforation secondary to intragastric balloon: endoscopic and surgical skills with literature review. Obes Surg [Internet]. 2020;30:4103–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32451921CrossRef

15.

Djelil D, Taihi L, Cattan P. Migration of an intragastric balloon may necessitate enterotomy for extraction. J Visc Surg [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33168475

16.

Koek SA, Hammond J. Gastric outlet obstruction secondary to orbera intragastric balloon. J Surg Case Reports [Internet]. 2018;2018:rjy284. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30386547

17.

Granek RJ, Hii MW, Ward SM. Major gastric haemorrhage after intragastric balloon insertion: case report. Obes Surg [Internet]. 2018;28:281–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29071537CrossRef

18.

Kumar N, Bazerbachi F, Rustagi T, et al. The influence of the orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events: a systematic review and meta-analysis. Obes Surg [Internet]. 2017;27:2272–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28285471CrossRef

19.

Barola S, Agnihotri A, Chiu AC, et al. Spontaneous hyperinflation of an intragastric balloon 5 months after insertion. Am J Gastroenterol [Internet]. 2017;112:412. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28270675CrossRef

20.

Quarta G, Popov VB. Intragastric balloon hyperinflation secondary to polymicrobial overgrowth associated with proton pump inhibitor use. Gastrointest Endosc [Internet]. 2019;90:311–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30935931CrossRef

21.

Barrichello S, de Moura DTH, Hoff AC, et al. Acute pancreatitis due to intragastric balloon hyperinflation (with video). Gastrointest Endosc [Internet]. 2020;91:1207–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31866316CrossRef

22.

Alsohaibani FI, Alkasab M, Abufarhaneh EH, et al. Acute pancreatitis as a complication of intragastric balloons: a case series. Obes Surg [Internet]. 2019;29:1694–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30826913CrossRef

23.

Alqabandi O, Almutawa Y, AlTarrah D, et al. Intragastric balloon insertion and pancreatitis: case series. Int J Surg Case Rep [Internet]. 2020;74:263–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32905925CrossRef

24.

Gore N, Ravindran P, Chan DL, et al. Pancreatitis from intra-gastric balloon insertion: xase report and literature review. Int J Surg Case Rep [Internet]. 2018;45:79–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29579540CrossRef

25.

Barrichello Junior S, Ribeiro I, Fittipaldi-Fernandez R, et al. Exclusively endoscopic approach to treating gastric perforation caused by an intragastric balloon: case series and literature review. Endosc Int Open. 2018;06:E1322–9. https://doi.org/10.1055/a-0743-5520

26.

Perez Aguado G, Cabrera Marrero JC, Jiménez-Ruano L. Combined endoscopy and laparoscopic approach of a gastric perforation due to intragastric balloon insertion. Rev Española Enfermedades Dig [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33228373

27.

Albaugh VL, Williams DB, Aher C V, Spann MD, English WJ. Prevalence of thiamine deficiency is significant in patients undergoing primary bariatric surgery. Surg Obes Relat Dis [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33478908

28.

Vellante P, Carnevale A, D’Ovidio C. An autopsy case of misdiagnosed Wernicke’s Syndrome after intragastric balloon therapy. Case Rep Gastrointest Med [Internet]. 2018;2018:1–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29666718CrossRef

29.

Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition [Internet]. 2010;26:1031–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20363593CrossRef

30.

Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology. Surg Obes Relat Dis [Internet]. 2020;16:175–247. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31917200CrossRef

31.

Paspatis GA, Arvanitakis M, Dumonceau J-M, et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement – Update 2020. Endoscopy [Internet]. 2020;52:792–810. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32781470CrossRef

32.

Dai S-C, Paley M, Chandrasekhara V. Intragastric balloons: an introduction and removal technique for the endoscopist. Gastrointest Endosc [Internet]. 2015;82:1122. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0016510715025328CrossRef

33.

Neto G, Campos J, Ferraz A, et al. An alternative approach to intragastric balloon retrieval. Endoscopy [Internet]. 2016;48:E73. Available from. https://doi.org/10.1055/s-0042-101856.CrossRef

34.

Cambi MPC, Baretta GAP, Magro DDO, Boguszewski CL, Ribeiro IB, Jirapinyo P, et al. Multidisciplinary approach for weight regain—how to manage this challenging condition: an expert review. Obes Surg. 2021;31:1290–1303. https://doi.org/10.1007/s11695-020-05164-1

Titel: Adverse Events and Complications with Intragastric Balloons: a Narrative Review (with Video)
Publikationsdatum: 30.03.2021
Erschienen in: Obesity Surgery / Ausgabe 6/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-021-05352-7

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2021

The Impact of Gastric Bypass on Telomere Length and Shelterin Complex Gene Expression: 6 Months Prospective Study

C Peptide Fails to Improve the Utility of the DiaRem Algorithm in Predicting Remission of Type II Diabetes After Bariatric Surgery

Vitamin D in the Preoperative and Postoperative Periods of Bariatric Surgery

Reply to: Pregnancy After Bariatric Surgery: a Matter of Indications and Procedures?

Laparoscopic Sleeve Gastrectomy Following Failed Laparoscopic Adjustable Gastric Banding—a Comparison Between One- and two-Stage Procedures, an Israeli National Database Study

Missing Jejunal Perforation During Small Bowel Measurement in Patient Operated by Laparoscopic One-Anastomosis Gastric Bypass

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“